56%), though this apparent difference did not reach statistical significance ( Figure 1 F ).
← all excerpts
SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma.
1
—
—
56%), though this apparent difference did not reach statistical significance ( Figure 1 F ).